Healthcare Industry Contract Manufacturing Top API Suppliers

Everything you need to know about ranking of global API suppliers

download (4)
API Contract Manufacturing

API, active pharmaceutical ingredient is key spend line item  for pharmaceutical companies. In order to have strategic alliance with right vendor, one should evaluate API manufacturing experience that each vendor carries. Best way to check API mfg strength of potential strategic vendors is by evaluating their US DMF count. Below is the list of top 10 US DMF holders in Type II category.

 

Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product

Company US DMF Count
TEVA or TAPI 311 ( website says 370 APIs )
MSN 266 ( website says 152 APIs )
AUROBINDO PHARMA 215 (SEC filings states 220 APIs)
MYLAN 213 ( website says 250 APIs )
DR REDDY 205 ( website says 450 + globally)
HETERO DRUGS 202
LUPIN 182
SUN PHARMA 160
CIPLA 156
CADILA 137

As expected, market was led by TAPI which holds close to 311 DMFs under Type II DMF category, followed by MSN, Aurobindo, Mylan & Dr Reddy.

Below are some important points from analysis:

  • Total of 10243 active DMF count were recorded in Type II DMF category.
  • Top 12 players accounted for ~23% of overall DMF count, with more than quarter of this 23% coming from Teva and MSN alone.
  • Only 5 companies accounted for greater than 2% of DMF count share, and included likes of Dr Reddy, Aurobindo Pharma, Mylan and two mentioned in above point.

DMF count might appear as just another number but it is one of the most important KPI to understand vendor’s technical know-how. Hence, the above mentioned vendors if part of your incumbent list, should be retained as is, and must be transitioned to strategic vendors going forward. If otherwise, these suppliers must be positioned in your preferred partner list, probably for future consignments mapped to large volumes.

Source 1 : http://www.msnlabs.com/api-dmfs.html

Source 2 : http://www.aurobindo.com/docs/press-room/press-reports/aurobindo-pharma-ltd-q4-fy-16-17-and-fy-1617-press-release.pdf

Source 3 : https://www.tapi.com/ProductCatalog.pdf?v=812

Source 4 : http://www.mylan.in/en/manufacturing-and-scientific-affairs/manufacturing/active-pharmaceutical-ingredients

Source 5 :http://www.drreddys-cps.com/apis-and-intermediates/commercial-supplies/

 

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s